Nuclear factor-{kappa}B regulates β-cell death: A critical role for A20 in β-cell protection

Diabetes

Volumn 55, Issue 9, 2006, Pages 2491-2501

  Liuwantara, David ^a   Elliot, Mark ^b   Smith, Mariya W ^b   Yam, Andrew O ^a   Walters, Stacy N ^a   Marino, Eliana ^a   McShea, Andy ^b   Grey, Shane T ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b CombiMatrix Corporation ^*  (United States)

Author keywords

gal, galactosidase; FACS, fluorescence activated cell sorter; FADD, Fas associated death domain; FADDDN, FADD dominant negative inhibitor; IFN, interferon; IL, interleukin; I kappa B alpha , inhibitor of NF kappa B

Indexed keywords

CYTOKINE; ENDOGENOUS COMPOUND; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OLIGONUCLEOTIDE; PROTEIN KINASE D; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; INTERLEUKIN 1; NF KAPPA B KINASE; NF-KAPPA B KINASE; NUCLEAR PROTEIN; PROTEIN; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN; TNFAIP3 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; DNA MICROARRAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DEATH; GENE EXPRESSION PROFILING; HUMANS; INSULIN-SECRETING CELLS; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; NF-KAPPA B; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 33750577982     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0142     Document Type: Article

References (54)

1. Green DR: Apoptotic pathways: the roads to ruin. Cell 94:695-698, 1998
2. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on apoptosis (Review). Cell 76:777-779, 1994
3. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S: Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741, 1997
4. Scaglia L, Smith FE, Bonner-Weir S: Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology 136:5461-5468, 1995
5. Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 414:792-798, 2001
6. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL: Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl. 2):S97-S107, 2005
7. Delovitch TL, Singh B: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738, 1997 [Erratum in Immunity 8:531, 1998]
8. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
9. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML: Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol 270:C1581-C1587, 1996
10. Ricordi C, Strom TB: Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 4:259-268, 2004
11. Lechler RI, Garden OA, Turka LA: The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 3:147-158, 2003
12. Weir GC, Bonner-Weir S: Scientific and political impediments to successful islet transplantation. Diabetes 46:1247-1256, 1997
13. Grey ST, Longo C, Shukri T, Patel VI, Csizmadia E, Daniel S, Arvelo MB, Tchipashvili V, Ferran C: Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J Immunol 170:6250-6256, 2003
14. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL: Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50:909-920, 2001
15. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, Eizirik DL: A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276:48879-48886, 2001
16. Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782-784, 1996
17. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NFkappaB. Science 274:787-789, 1996
18. Wang CY, Mayo MW, Baldwin AS Jr: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784-787, 1996
19. Bach FH, Hancock WW, Ferran C: Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 18:483-486, 1997
20. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, Soares M, Grey ST, Bach FH: A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91:2249-2258, 1998
21. Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C: A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB- dependent gene activation in islets. J Exp Med 190:1135-1146, 1999
22. Daniel S, Arvelo MB, Patel VI, Longo CR, Shrikhande G, Shukri T, Mahiou J, Sun DW, Mottley C, Grey ST, Ferran C: A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 104:2376-2384, 2004
23. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW: Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 153:3664-3672, 1994
24. Gunther L, Berberat PO, Haga M, Brouard S, Smith RN, Soares MP, Bach FH, Tobiasch E: Carbon monoxide protects pancreatic β-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51:994-999, 2002
25. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell P J, Gonzalez FJ, Kahn CR: Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337-349, 2005
26. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, Grey ST, Lowell BB: Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112:1831-1842, 2003
27. D'Ambra R, Surana M, Efrat S, Starr RG, Fleischer N: Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology 126:2815-2822, 1990
28. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML: Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 136:4790-4795, 1995
29. Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
30. Ainbinder E, Revach M, Wolstein O, Moshonov S, Diamant N, Dikstein R: Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol 22:6354-6362, 2002
31. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H: Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J Clin Invest 99:763-772, 1997
32. Storz P, Doppler H, Ferran C, Grey ST, Toker A: Functional dichotomy of A20 in apoptotic and necrotic cell death. Biochem J 387:47-55, 2005
33. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA: IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 102:516-526, 1998
34. Cetkovic-Cvrlje M, Eizirik DL: TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6:399-406, 1994
35. Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J, Kay TW: IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53:113-121, 2004
36. Dahlen E, Dawe K, Ohlsson L, Hedlund G: Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 160:3585-3593, 1998
37. Pakala SV, Chivetta M, Kelly CB, Katz JD: In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 189:1053-1062, 1999
38. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP: Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 277:17950-17961, 2002
39. Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227, 2002
40. Opipari AW Jr, Boguski MS, Dixit VM: The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Bio Chem 265:14705-14708, 1990
41. Werner SL, Barken D, Hoffmann A: Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309:1857-1861, 2005
42. Krikos A, Laherty CD, Dixit VM: Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Bio Chem 267:17971-17976, 1992
43. May MJ, Ghosh S: Signal transduction through NF-kappa B. Immunol Today 19:80-88, 1998
44. Storz P, Toker A: Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J 22:109-120, 2003
45. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A: Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350-2354., 2000
46. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM: De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694-699, 2004
47. Darville MI, Eizirik DL: Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-{kappa}B and C/EBP. Diabetes 50:1741-1748, 2001
48. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL: Inhibition of cytokine-induced NF-{kappa}B activation by adenovirus-mediated expression of a NF-{kappa}B super-repressor prevents β-cell apoptosis. Diabetes 50:2219-2224, 2001
49. Kwon G, Corbett JA, Hauser S, Hill JR, Turk J, McDaniel ML: Evidence for involvement of the proteasome complex (26S) and NF{kappa}B in IL-1β-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes 47:583-591, 1998
50. Sorli CH, Zhang HJ, Armstrong MB, Rajotte RV, Maclouf J, Robertson RP: Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A 95:1788-1793, 1998
51. Giannoukakis N, Rudert WA, Trucco M, Robbins PD: Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem 275:36509-36513, 2000
52. Wong GH, Elwell JH, Oberley LW, Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931, 1989
53. Chang I, Kim S, Kim JY, Cho N, Kim YH, Kim HS, Lee MK, Kim KW, Lee MS: Nuclear factor{kappa}B protects pancreatic β-cells from tumor necrosis factor-{alpha}-mediated apoptosis. Diabetes 52:1169-1175, 2003
54. Giannoukakis N, Rudert WA, Ghivizzani SC, Gambotto A, Ricordi C, Trucco M, Robbins PD: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1β-induced β-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 48:1730-1736, 1999